Hilde Wik

8PUBLICATIONS

57CO-AUTHORS

Haematological tumoursPharmacogenomicsLiquid biopsiesMajor global burdens of diseasePredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 18, 2026

Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications.

|Sep 08, 2025

Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric Patients.

Tianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann

|Jul 29, 2025

Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL).

Mirjam Podgorica, Elsa Drivet, Johanne Vestbøstad

|Jan 09, 2024

Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.

Mirjam Podgorica, Elsa Drivet, Jonas Krag Viken

|Aug 22, 2022

Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.

Ingrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf

|Jul 21, 2022

"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply.

Trine-Lise Larsen, Herish Garresori, Jorunn Brekke

Pageof 2

Frequent Collaborators

Susan R Kahn

Ingrid M Bistervels

Roisin Bavalia

Karina Meijer

Francis Couturaud

Peter Verhamme

Per Morten Sandset

Barbara A Hutten

Waleed Ghanima

Saskia Middeldorp

Frequent Collaborators

Susan R Kahn

Ingrid M Bistervels

Roisin Bavalia

Karina Meijer